Understanding Adipose Tissue Dysfunction

Area of Science:

• Endocrinology
• Metabolic disease research
• Adipose tissue biology

Background:

• Diseases like obesity, lipodystrophy, and lipedema affect adipose tissue (AT) function.
• Both AT deficiency and excess AT increase risks for type 2 diabetes, hypertension, sleep apnea, and cancer.
• Individual disease risk isn't solely determined by fat mass; AT dysfunction is a key mechanistic link.

Purpose of the Study:

• To review recent advances in understanding adipose tissue biology.
• To explore the role of AT dysfunction in obesity-related comorbidities.
• To identify key questions regarding AT dysfunction mechanisms and potential reversal.

Main Methods:

• Literature review of recent scientific advances in AT biology.
• Analysis of the characteristics and implications of AT dysfunction.
• Discussion of factors contributing to AT heterogeneity and dysfunction.

Main Results:

• AT dysfunction involves adipocyte hypertrophy, impaired expandability, hypoxia, inflammation, and release of harmful signals.
• Metabolically healthy individuals exist despite obesity, while normal-weight individuals can develop obesity-related diseases.
• Genetic and environmental factors interact to influence AT heterogeneity and dysfunction.

Conclusions:

• AT dysfunction, rather than excess fat, is a critical factor in obesity-related diseases.
• Further research is needed to understand AT dysfunction mechanisms, subtypes, and therapeutic strategies.
• Investigating AT signatures and environmental impacts can improve AT health and disease management.